Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: This year’s National Health Interview Survey was the first to ask about sexual orientation in addition to health habits in its 57-year history, the U.S. Centers for Disease Control and Prevention said. Bisexual women were twice as likely to experience serious anxiety while bisexual men were more likely to indulge in binge drinking than others, according to the survey. In the survey of more than 34,500 Americans age 18 and above, 1.6 percent reported that they were gay and 0.7 percent reported that they were bisexual. A total of 96.6 percent reported being straight and 1.1 percent either said they were “something else,” did not know or declined to answer. Roughly twice as many women than men identified as bisexual, with 0.9 percent of female respondents saying they were attracted to both sexes. Bisexual women were twice as likely to report having serious anxiety than any other group, with almost 11 percent saying they had been distressed in the past month. Among bisexual men, almost 52 percent said they had five drinks or more in a night during the past year compared with only 31 percent of straight men. Gays and bisexuals fared as well or better than their straight peers in some areas, like exercising, taking HIV tests and receiving flu vaccines. “The differences went both ways, and it depends on the specific indicator that you were looking at,” said Brian Ward, a lead author on the survey and health statistician for the CDC’s statistical arm. The CDC said the survey findings were in line with other  research on health and sexual orientation, though a smaller proportion of people in this survey identified as bisexual than in other studies.

Output: Government report finds 2.3 percent of Americans gay or bisexual.


Input: Consider Input: The Associated Press has learned that the attorneys general in Illinois and the District of Columbia are examining how Juul’s blockbuster vaping device became so popular with underage teens. The company’s rapid rise to the top of the multi-billion dollar U.S. e-cigarette market has been accompanied by accusations from parents, politicians and public health advocates that Juul fueled a vaping craze among high schoolers. In addition to the ongoing inquiries in Illinois and the district, which had not been publicly disclosed before, four other state attorneys general are probing or suing Juul. Juul’s top executives have disputed allegations that they’ve marketed their products to teens, declaring that they’ve taken unprecedented steps to combat underage use of its e-cigarettes. The company has shut down its Facebook and Instagram pages and pulled several of its flavored products out of retail stores. Juul also backs federal legislation to raise the minimum age to purchase all tobacco products, including e-cigarettes, to 21 nationwide. Juul spokesman Ted Kwong declined to answer specific questions about the investigations in an emailed statement but reiterated past company steps to prevent youth use. Juul announced Thursday that 50 retail chains have pledged to adopt the company’s age-verification system, which requires sellers to scan a customer’s ID before selling Juul products. Health and Human Services Secretary Alex Azar said in a statement Friday the Trump administration “will continue using every regulatory and enforcement power we have to stop the epidemic of youth e-cigarette use.” A senior Illinois law enforcement official described to AP a wide-ranging inquiry being conducted by the office of Illinois Attorney General Kwame Raoul that is centered on whether Juul violated state consumer fraud laws and other statutes by designing and marketing its products to appeal to underage teens. The official was not authorized to speak publicly and requested anonymity. Marrisa Geller, a spokeswoman for District of Columbia Attorney General Karl Racine, confirmed in an emailed statement an investigation of Juul is underway. She said Racine is concerned about “the dramatic increase in the use of vaping products by district youth” as well as the policies and practices employed by e-cigarette manufacturers to prevent minors from using their products. The attorneys general in Colorado, Connecticut and Massachusetts have announced investigations of Juul related to concerns over underage use of its products. North Carolina’s attorney general filed a lawsuit against Juul in May, asking a court to limit the company’s sales and marketing in the state. All six attorneys general are Democrats. The Food and Drug Administration said last October it seized thousands of documents from Juul’s San Francisco headquarters relating to the company’s marketing. The agency has been investigating whether the company targeted youth with the flavors, design and ingredients of its products. The Wall Street Journal reported Friday that the Federal Trade Commission is investigating Juul’s early marketing campaign and use of social media to promote its products. The FTC declined to comment. Juul has repeatedly stated that it understands the concerns about youth vaping and has taken “the most aggressive actions” of any company in the industry to combat the problem. It has spent millions of dollars on newspaper, radio and online advertisements pledging to keep its products out of the hands of young people. The company also has denied it ever marketed to anyone underage. Kwong said Juul’s earliest marketing campaign, in 2015, was aimed at adults between 25 and 34. Based on the sales and revenue, he said, “there is no evidence that it drove use, youth or otherwise.” Kwong said the company’s paid social media “influencer” program was as a small, short-lived program that ended in 2018. Electronic cigarettes, which have been available in the U.S. since about 2007 and have grown into a more than $6 billion-a-year industry, are battery-powered devices that typically heat a flavored nicotine solution into an inhalable aerosol. Juul, which launched in 2015, now controls roughly three-quarters of the U.S. retail market for e-cigarettes. Last year, one in five U.S. high school students reported vaping in the previous month, according to government survey figures. Most experts agree the aerosol is less harmful than cigarette smoke since it doesn’t contain most of the cancer-causing byproducts of burning tobacco. But there is virtually no research on the long-term effects of the vaping chemicals, some of which are toxic. The Centers for Disease Control and Prevention said Friday that 215 teens and adults in 25 states including Illinois have contracted severe respiratory illnesses after vaping. However, the agency said a clear-cut common cause of the illnesses hasn’t been identified and they are being called “potential cases” that are still under investigation. The CDC said in many of the cases patients had acknowledged they’d recently vaped a substance containing THC, the high-inducing ingredient in marijuana. The agency did not say how many of the patients were teens. Kevin Burns, Juul’s chief executive officer, told “CBS This Morning” on Wednesday the illnesses are “worrisome” for the industry and for Juul “if we contributed to it.” He said the company is in close contact with the CDC to get as much information as it can “so if there’s any issue that was ... associated with us, that we can get to the root cause and understand that.” In Illinois, the state’s Department of Public Health has called e-cigarette use among teens an “epidemic” and said there is an alarming lack of understanding about the risk for nicotine addiction. Other areas being investigated by Raoul’s office include: how Juul verifies the ages of people who make online purchases from the company’s website; the amount of nicotine in the flavored solution and how safe those levels are; and whether Juul has improperly advertised its e-cigarette as a smoking-cessation tool. Kwong said the Juul system is designed to help adult smokers switch from combustible cigarettes and is not intended to be used as a cessation product. Neither Juul nor any other e-cigarette has yet been approved by the FDA to help people who smoke traditional paper-and-tobacco cigarettes quit. The Illinois probe began in the spring. Raoul’s office is not coordinating its investigation with other attorneys general, the official said. Geller, the spokeswoman for Racine, declined to discuss the scope of the district’s inquiry. However, a senior official in Racine’s office wrote to a Juul representative in early February and asked for a trove of information about how district residents purchase the company’s products. Among the data sought by Benjamin Wiseman, director of consumer protection, was a list of authorized retail stores and third-party online retailers that failed to comply with Juul’s rules for preventing minors from buying and using its products. Wiseman also asked that the company “describe in detail the nature of the retailer’s failure to comply” and what action Juul took in response. Racine’s office, Wiseman wrote, learned from news reports and conversations with community members and other government officials that use of Juul’s products by young teenagers in the district has increased dramatically in recent years. “Remarkably, one district high school principal estimates that half of the juniors and seniors at her school are using e-cigarettes, many of which we believe are Juul’s products,” Wiseman told Patrick Lynch, a former attorney general of Rhode Island who runs a lobbying and consulting firm that represents Juul. Lynch’s firm arranged for a meeting in the attorney general’s office last November that included himself, Juul chief administrative officer Ashley Gould, Wiseman and Assistant DC Attorney General Brian Caldwell, according to emails obtained through an open records request. Lynch is not registered as a lobbyist in the District of Columbia. The agenda for the meeting isn’t described in the records, although one email from Lynch said they discussed Juul’s efforts “to dramatically diminish youth access to their product.”

Output: Juul Labs facing scrutiny from federal and state officials.


Input: Consider Input: "There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release."


Output: MS pills show promise and risk, studies say